The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...
Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as ...
Ozanimodâ–¼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
(Legal Fee Tracker is a weekly feature focused on attorney compensation. Please send tips or suggestions to ...
Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform. | Neomorph is ...
RFK Jr. plans to keep collecting referral fees in lawsuits against the drug company Merck even if confirmed as HHS secretary, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback